Startups channel feed

A start­up backed by No­bel win­ner David Bak­er takes an AI twist on an­ti­bod­ies

6 months ago
Financing
AI

Ax­o­nis snags $115M to test oral drugs for epilep­sy and neu­ro­path­ic pain

6 months ago
Financing

Cor­rect­ed: Gen­mab lines up T cell en­gager pact with Re­vi­tope

6 months ago
Deals
Pharma

Ab­b­Vie makes $1.4B ac­qui­si­tion of Alzheimer's biotech

6 months ago
Deals
Pharma

Synaf­fix, in­dus­try's ADC part­ner of choice, spins out a start­up pipeline

6 months ago
Financing

For­mer Seagen CEO David Ep­stein to lead new biotech with VEGF bi­func­tion­al an­ti­body

6 months ago
R&D

Fog­Phar­ma re­brands as Para­bilis Med­i­cines, as CEO Math­ai Mam­men high­lights next drugs

6 months ago
R&D

Telix's new ra­dio­phar­ma spin­out banks on one tri­al for suc­cess, CEO says

6 months ago
Manufacturing

Elu­ci­da On­col­o­gy, seek­ing foothold in AD­Cs, shut­ters due to 'lack of fund­ing'

6 months ago
People

Septer­na bags $288M up­sized IPO for GPCR drugs

6 months ago
Financing

Sanofi backs fi­bro­sis biotech Agomab as it rais­es $89M Se­ries D

6 months ago
Financing
Pharma

Ra­dio­phar­ma star­tups stay hot as Al­pha-9 bags $175M Se­ries C

6 months ago
Financing

Life sci­ences in­vestor Di­men­sion seeks to raise $500M sec­ond fund

6 months ago
Financing

Hous­ton start­up March Bio­sciences rais­es $28M to get CAR-T in­to Phase 2

6 months ago
Financing
Cell/Gene Tx

Eye drop mak­er to merge with a reti­nal gene ther­a­py start­up from Spark co-founder

6 months ago
Deals
Cell/Gene Tx

Be Bio rais­es $82M to fund work on B cell ther­a­py in he­mo­phil­ia B

6 months ago
Financing
R&D

Q3 biotech roundup: The 2024 turn­around sput­ters in­to a crit­i­cal Q4 fi­nale

6 months ago
Financing
Bioregnum

Septer­na out­lines $157M IPO af­ter en­ter­ing the clin­ic with GPCR pipeline

6 months ago
Financing

For­mer Karuna crew quick­ly as­sem­bles $225M for next neu­ro bet at Sea­port

6 months ago
Financing

Se­cre­tive Tree­line Bio­sciences dis­clos­es $421M fi­nanc­ing in fil­ing

6 months ago
Financing

RNA gene ther­a­py start­up Shape hunts for new CEO as Se­ries C awaits

6 months ago
People
Cell/Gene Tx

Hos­pi­tals gush about new AI note-tak­ing tools. It may leave the hu­man med­ical scribes who orig­i­nat­ed the roles be­hind

6 months ago
AI
Health Tech

Life sci­ences in­vestor KdT Ven­tures rais­es $100M fund to back new star­tups

6 months ago
Financing

Seek­ing to treat obe­si­ty drug side ef­fect, Neu­ro­gas­trx re­leas­es da­ta on drug for GLP-1-as­so­ci­at­ed nau­sea, vom­it­ing

6 months ago
R&D
First page Previous page 6789101112 Next page Last page
A service from the Financial Times